Clorox CLX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 45.2%+2.3pp | 43%+3.6pp | 39.4%+3.5pp | 35.8%-7.8pp | |
| Net margin | 11.4%+7.5pp | 3.9%+1.9pp | 2%-4.5pp | 6.5%-3.2pp | |
| Returns | |||||
| Return on equity | 249.6%+147pp | 102.2%+63.8pp | 38.4%-57.2pp | 95.6%-12.1pp | |
| Return on invested capital | 29.1%+16.9pp | 12.2%+4.9pp | 7.3%-9.6pp | 17%-7.8pp | |
| Efficiency | |||||
| Asset turnover | 1.3×0.0× | 1.2×0.0× | 1.2×+0.1× | 1.1×0.0× | |
| Liquidity | |||||
| Current ratio | 0.8×-0.2× | 1×+0.1× | 1×0.0× | 1×+0.1× | |
| Leverage | |||||
| Debt-to-equity | 9.1×+0.1× | 9×-4.5× | 13.4×+8.2× | 5.2×-2.6× | |
| Net debt / EBITDA | 2×-1.8× | 3.8×-0.8× | 4.6×+1.7× | 2.9×+0.5× | |
| Per Share | |||||
| Book value per share | $2.58-1.7% | $2.63+48.3% | $1.77-60.5% | $4.49+39.0% | |
| Valuation | |||||
| Market capitalization | $15.04B-11.3% | $16.95B-13.8% | $19.66B+13.3% | $17.35B-21.5% | |
| Price / earnings | 18.6×-42.0× | 60.5×-71.4× | 132×+94.4× | 37.6×+6.4× | |
| Price / sales | 2.1×-0.3× | 2.4×-0.3× | 2.7×+0.2× | 2.4×-0.6× | |
| Price / book | 46.9×-4.8× | 51.7×-37.7× | 89.4×+58.2× | 31.2×-22.6× | |
| EV / EBITDA | 12.8×-14.4× | 27.2×-12.2× | 39.4×+18.0× | 21.4×+0.8× | |
| Dividend yield | 4%+0.5pp | 3.5%+0.5pp | 3%-0.3pp | 3.3%+0.8pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Clorox's ratios come from?
- Every ratio is computed from Clorox's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
